Importantly, S1R activation, e.g., by pridopidine, enhances neuroprotective effects in preclinical models of neurodegeneration, including HD and ALS, acting to stimulate brain repair and plasticity. This evidence concerns the gene TMBIM4 and amyotrophic lateral sclerosis.